Correction: Cost of gene therapy
- PMID: 38172433
- DOI: 10.1038/s41434-023-00432-y
Correction: Cost of gene therapy
Erratum for
-
Cost of gene therapy.Gene Ther. 2023 Nov;30(10-11):737. doi: 10.1038/s41434-023-00408-y. Gene Ther. 2023. PMID: 37938351 No abstract available.
References
-
- Kohn DB, Chen YY, Spencer MJ. Successes and challenges in clinical gene therapy. Gene Ther. 2023. https://doi.org/10.1038/s41434-023-00390-5 - DOI - PubMed - PMC
-
- Witkowsky L, Norstad M, Glynn AR, Kliegman M. Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute. Gene Ther. 2023. https://doi.org/10.1038/s41434-023-00392-3 - DOI - PubMed - PMC
-
- Joffe S, Conti RM, Contreras JL, Largent EA, Lynch HF, Mitchell D, et al. Access to affordable medicines: obligations of universities and academic medical centers. Gene Ther. 2023. https://doi.org/10.1038/s41434-023-00393-2 - DOI - PubMed
-
- Vokinger KN, Glaus CEG, Kesselheim AS. Approval and therapeutic value of gene therapies in the US and Europe. Gene Ther. 2023. https://doi.org/10.1038/s41434-023-00402-4 - DOI - PubMed
-
- Wong CH, Li D, Wang N, Gruber J, Lo AW, Conti RM. The estimated annual financial impact of gene therapy in the United States. Gene Ther. 2023. https://doi.org/10.1038/s41434-023-00419-9 - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources